Monday June 26th 2017

Archive for June, 2011

MS sufferer happy with government announcement

MS sufferer happy with government announcement

Karen Torrie-Racine was “thrilled” to hear the federal government has agreed to fund clinical trials of a controversial multiple sclerosis treatment called chronic cerebrospinal venous insufficiency. “Like everyone, I’m just really anxious for the [Read More]

MS vein therapy trial decision ‘unexpected’

MS vein therapy trial decision ‘unexpected’

The federal government’s decision to hold clinical trials for an experimental multiple sclerosis treatment is getting a mixed reaction. Health Minister Leona Aglukkaq announced on Wednesday that Ottawa will launch early stage clinical trials into using angioplasty to [Read More]

Funding ‘liberation’ treatment trials not enough, says Ottawa MS patient

Funding ‘liberation’ treatment trials not enough, says Ottawa MS patient

An Ottawa man who travelled to Poland more than a year ago for a controversial multiple sclerosis treatment says Wednesday’s announcement that Canada will fund clinical trials of the procedure doesn’t go far enough. “While it’s good to see research go forward, this [Read More]

 Page 1 of 10  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]